Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.

Pokaži ostale verzije (1)

Bibliografski detalji
Glavni autori:	Hanekom, W, Dockrell, H, Ottenhoff, T, Doherty, T, Fletcher, H, Mcshane, H, Weichold, F, Hoft, D, Parida, S, Fruth, U
Format:	Journal article
Jezik:	English
Izdano:	2008

Slični predmeti

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
od: Hanekom, W, i dr.
Izdano: (2008)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
od: Willem A Hanekom, i dr.
Izdano: (2008-07-01)

A comparison of IFNgamma detection methods used in tuberculosis vaccine trials.
od: Beveridge, N, i dr.
Izdano: (2008)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
od: Dockrell, HM, i dr.
Izdano: (2022)

Tuberculosis vaccines: current status and future prospects.
od: Fletcher, H, i dr.
Izdano: (2006)

Local pulmonary immunological biomarkers in tuberculosis
od: Morrison, H, i dr.
Izdano: (2021)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
od: Mcshane, H, i dr.
Izdano: (2016)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
od: Fletcher, H, i dr.
Izdano: (2009)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
od: Fletcher, H, i dr.
Izdano: (2013)

Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis.
od: Smith, S, i dr.
Izdano: (2009)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
od: Hazel M. Dockrell, i dr.
Izdano: (2022-05-01)

Vaccines for tuberculosis
od: McShane, H
Izdano: (2013)

TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development
od: Kaufmann, S, i dr.
Izdano: (2017)

Tuberculosis vaccines
od: W. Hanekom
Izdano: (2014-04-01)

Vaccine strategies against tuberculosis.
od: Mcshane, H
Izdano: (2009)

Developing an improved vaccine against tuberculosis.
od: Mcshane, H
Izdano: (2004)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG immunized adults vaccinated with a new tuberculosis vaccine, MVA85A (Clinical and Vaccine Immunology (2010) 17, 7, (1066-1073))
od: De Cassan, S, i dr.
Izdano: (2011)

Vaccine strategies against tuberculosis
od: H McShane
Izdano: (2009-03-01)

Local Pulmonary Immunological Biomarkers in Tuberculosis
od: Hazel Morrison, i dr.
Izdano: (2021-03-01)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
od: Griffiths, K, i dr.
Izdano: (2011)

WHO preferred product characteristics for new vaccines against tuberculosis
od: Schrager, L, i dr.
Izdano: (2018)

Tuberculosis vaccines: present and future.
od: Minassian, A, i dr.
Izdano: (2008)

Tuberculosis vaccines in clinical trials.
od: Rowland, R, i dr.
Izdano: (2011)

Tuberculosis vaccines: progress and challenges.
od: Checkley, A, i dr.
Izdano: (2011)

Insights and challenges in tuberculosis vaccine development
od: McShane, H
Izdano: (2019)

Tuberculosis vaccines: Progress and challenges
od: Checkley, A, i dr.
Izdano: (2011)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
od: McShane, H
Izdano: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
od: McShane, H
Izdano: (2011)

Tuberculosis vaccine promises sterilizing immunity.
od: Mcshane, H, i dr.
Izdano: (2011)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
od: Hawkridge, T, i dr.
Izdano: (2008)

Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
od: Stefan H. E. Kaufmann, i dr.
Izdano: (2020-02-01)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
od: Mcshane, H, i dr.
Izdano: (2017)

Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
od: Dintwe, O, i dr.
Izdano: (2013)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
od: Griffiths, K, i dr.
Izdano: (2013)

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.
od: Sander, C, i dr.
Izdano: (2007)

The future of vaccines for tuberculosis
od: Stockdale, L, i dr.
Izdano: (2019)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
od: McShane, H
Izdano: (2023)

Clinical testing of tuberculosis vaccine candidates
od: Hatherill, M, i dr.
Izdano: (2016)

Why don’t we have an effective tuberculosis vaccine yet?
od: Davenne, T, i dr.
Izdano: (2016)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
od: Mcshane, H, i dr.
Izdano: (2005)